New York’s Department of Financial Services (DFS) has filed insurance fraud charges against opioid manufacturers Teva Pharmaceuticals and Allergan Plc.
According to a statement from Governor Andrew Cuomo, the DFS alleged in its filing that both Teva and Allergan took part in fraudulent marketing and promotional campaigns – campaigns which misrepresented the safety and effectiveness of opioid drugs.
Reuters reached out to both Teva and Allergan for comment, but neither were able to immediately respond.
Read more: Healthcare fraud tops $2 billion for tenth year in a row
In 2019, opioid manufacturer Insys Therapeutics paid $195 million to settle civil allegations that it gave kickbacks to physicians and nurses, bribing them to prescribe the company’s own drug Subsys for patients.
